Companies: โ€”ยทtotal market cap: โ€”
$ USD
companiesbycap
Menu
Global rankingSuperinvestors
Countries
๐Ÿ‡บ๐Ÿ‡ธUnited States๐Ÿ‡จ๐Ÿ‡ฆCanada๐Ÿ‡ฉ๐Ÿ‡ชGermany๐Ÿ‡ซ๐Ÿ‡ทFrance๐Ÿ‡ฌ๐Ÿ‡งUnited Kingdom๐Ÿ‡จ๐Ÿ‡ญSwitzerland๐Ÿ‡ฎ๐Ÿ‡ณIndia๐Ÿ‡ฏ๐Ÿ‡ตJapan
Categories
๐Ÿ’ปTechnology๐ŸฆFinancials๐Ÿ’ŠHealthcare๐Ÿ›๏ธConsumer Cyclical๐Ÿ“กCommunication๐ŸญIndustrials๐Ÿ›’Consumer DefensiveโšกEnergy
F
Flexion Therapeutics, Inc. FLXN
$25.14
โ–ฒ +0.32% 24H
24.7625.0825.4125.7326.052025-062025-092025-122026-032026-06

About

Flexion Therapeutics, Inc. is an American biopharmaceutical company that specializes in the discovery, development, and commercialization of innovative, locally administered therapies for musculoskeletal conditions. Founded in 2007 and headquartered in Burlington, Massachusetts, Flexion Therapeutics has built its scienโ€ฆ

Sectorโ€”
ExchangeNASDAQ
Industryโ€”
CountryUnited States
Employees0
TickerFLXN

Statistics

Market Cap$1.13B
Revenue (TTM)$85.6M
Net Income-$113.7M
Net Margin-132.9%
EPS$-2.53
P/E27.35
P/S0.00
P/B-15.81
EV/EBITDA-1.38
ROE14.5%
Dividend Yield3.02%
Price$25.14

Data: Twelve Data ยท Revenue = mcap / P/S

Flexion Therapeutics, Inc. (FLXN) โ€” Market Cap, Revenue, Net Income, P/E | companiesbycap